Synapsoft logo
AI Insights from Disclosures
Searching...
ISU Abxis Co., Ltd. 086890
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
ISU Abxis Co., Ltd.'s main products include Abcertin, Fabagal, and Clotinab. Abcertin is a drug used for long-term enzyme replacement therapy for Gaucher disease, a hereditary rare disease, and has been designated as a rare disease drug in Russia, with the company planning to expand into Europe.
Representative Director Yu Junsu
Founded March 29, 2001
Corporation Type KOSDAQ
Industry Classification Manufacture of medical supplies and related other medicaments
Corporate number 11011-2203951
Business number 110-81-50558
Phone Number 031-696-4700
Fax Number 031-696-4691
Website www.abxis.com
Company Address 22 Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant